{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:19:40Z","timestamp":1791505180244,"version":"4.3.4"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1093\/humrep\/16.12.2552","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T22:19:55Z","timestamp":1027721995000},"page":"2552-2556","source":"Crossref","is-referenced-by-count":74,"title":["Follistatin and activin A serum concentrations in obese and non-obese patients with polycystic ovary syndrome"],"prefix":"10.1093","volume":"16","author":[{"given":"T.","family":"Eldar-Geva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.M.","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.P.","family":"Groome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Margalioth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Homburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12]]},"reference":[{"key":"key\n\t\t\t\t20170410040147_ADAMS-ETAL-1985","doi-asserted-by":"crossref","unstructured":"Adams, J., Franks, S., Polson, D.W. et al. (1985) Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin-releasing hormone. Lancet, ii, 1375\u20131379.","DOI":"10.1016\/S0140-6736(85)92552-8"},{"key":"key\n\t\t\t\t20170410040147_DANILA-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Danila, D.C., Inder, W.J., Zhang, X. et al. (2000) Activin effects on neoplastic proliferation of human pituitary tumors. J. Clin. Endocrinol. Metab., 85, 1009\u20131015.","DOI":"10.1210\/jc.85.3.1009"},{"key":"key\n\t\t\t\t20170410040147_DANTONA-ETAL-2000","doi-asserted-by":"crossref","unstructured":"D'Antona, D., Reis, F.M., Benedetto, C. et al. (2000) Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders. J. Endocrinol., 165, 157\u2013162.","DOI":"10.1677\/joe.0.1650157"},{"key":"key\n\t\t\t\t20170410040147_DEMURA-ETAL-1993","unstructured":"Demura, R., Suzuki, T., Tajima, S. et al. (1993) Human plasma free activin and inhibin levels during the menstrual cycle. J. Clin. Endocrinol. Metab., 76, 1080\u20131082."},{"key":"key\n\t\t\t\t20170410040147_ERICKSON-ETAL-1995","doi-asserted-by":"crossref","unstructured":"Erickson, G.F., Chung, D.G., Sit, A. et al. (1995) Follistatin concentrations in follicular fluid of normal and polycystic ovaries. Hum. Reprod., 10, 2120\u20132124.","DOI":"10.1093\/oxfordjournals.humrep.a136246"},{"key":"key\n\t\t\t\t20170410040147_ESCH-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Esch, F.S., Shimasaki, S., Mercado, M. et al. (1987) Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad. Mol. Endocrinol., 1, 849\u2013855.","DOI":"10.1210\/mend-1-11-849"},{"key":"key\n\t\t\t\t20170410040147_EVANS-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Evans, L.W., Muttukrishna, S., Groome, N.P. et al. (1998) Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin. J. Endocrinol., 156, 275\u2013282.","DOI":"10.1677\/joe.0.1560275"},{"key":"key\n\t\t\t\t20170410040147_FLORIO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Florio, P., Luisi, S., Marchetti, P. et al. (2000) Activin A stimulates insulin secretion in cultured human pancreatic islets. J. Endocrinol. Invest., 23, 231\u2013234.","DOI":"10.1007\/BF03343713"},{"key":"key\n\t\t\t\t20170410040147_FOSTER-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Foster, C.M., Phillips, D.J., Wyman, T. et al. (2000) Changes in serum inhibin, activin and follistatin concentrations during puberty in girls. Hum. Reprod., 15, 1052\u20131057.","DOI":"10.1093\/humrep\/15.5.1052"},{"key":"key\n\t\t\t\t20170410040147_GUO-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Guo, Q., Kumar, T.R., Woodruff, T. et al. (1998) Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Mol. Endocrinol., 12, 96\u2013106.","DOI":"10.1210\/mend.12.1.0053"},{"key":"key\n\t\t\t\t20170410040147_HARADA-ETAL-1996","unstructured":"Harada, K., Shintani, Y., Sakamoto, Y. et al. (1996) Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J. Clin. Endocrinol. Metab., 81, 2125\u20132130."},{"key":"key\n\t\t\t\t20170410040147_HOMBURG-1998","doi-asserted-by":"crossref","unstructured":"Homburg, R. (1998) Involvement of growth factors in the pathophysiology of polycystic ovary syndrome. Gynecol. Endocrinol., 12, 391\u2013397.","DOI":"10.3109\/09513599809012841"},{"key":"key\n\t\t\t\t20170410040147_JONES-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Jones, K.L., Brauman, J.N., Groome, N.P. et al. (2000) Activin A release into the circulation is an early event in systemic inflammation and precedes the release of follistatin.Endocrinology, 141, 1905\u20131908.","DOI":"10.1210\/endo.141.5.7531"},{"key":"key\n\t\t\t\t20170410040147_KETTEL-ETAL-1996","unstructured":"Kettel, L.M., DePaolo, L.V., Morales, A.J. et al. (1996) Circulating levels of follistatin from puberty to menopause. Fertil. Steril., 65, 472\u2013476."},{"key":"key\n\t\t\t\t20170410040147_KHOURY-ETAL-1995","unstructured":"Khoury, R.H., Wang, Q.F., Crowley, W.F. Jr et al. (1995) Serum follistatin levels in women: evidence against an endocrine function of ovarian follistatin. J. Clin. Endocrinol. Metab., 80, 1361\u20131368."},{"key":"key\n\t\t\t\t20170410040147_KNIGHT-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Knight, P.G., Muttukrishna, S. and Groome, N.P. (1996) Development and application of a two-site enzyme immunoassay for the determination of `total' activin-A concentrations in serum and follicular fluid. J. Endocrinol., 148, 267\u2013279.","DOI":"10.1677\/joe.0.1480267"},{"key":"key\n\t\t\t\t20170410040147_KOZAKI-AND-OUCHI-1998","doi-asserted-by":"crossref","unstructured":"Kozaki, K. and Ouchi, Y. (1998) Activin\/follistatin and atherosclerosis\u2014a review. J. Atheroscler. Thromb., 5, 36\u201340.","DOI":"10.5551\/jat1994.5.36"},{"key":"key\n\t\t\t\t20170410040147_LAMBERT-MESSERLIAN-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Lambert-Messerlian, G., Taylor, A., Leykin, L. et al. (1997) Characterization of intrafollicular steroid hormones, inhibin, and follistatin in women with and without polycystic ovarian syndrome following gonadotropin hyperstimulation. Biol. Reprod., 57, 1211\u20131216.","DOI":"10.1095\/biolreprod57.5.1211"},{"key":"key\n\t\t\t\t20170410040147_LEGRO-ETAL-1998","unstructured":"Legro, R.S., Spielman, R., Urbanek, M. et al. (1998) Phenotype and genotype in polycystic ovary syndrome. Recent. Prog. Horm. Res., 53, 217\u2013256."},{"key":"key\n\t\t\t\t20170410040147_LIAO-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Liao, W.X., Roy, A.C. and Ng, S.C. (2000) Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome. Mol. Hum. Reprod., 6., 587\u2013590.","DOI":"10.1093\/molehr\/6.7.587"},{"key":"key\n\t\t\t\t20170410040147_LOCKWOOD-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Lockwood, G.M., Muttukrishna, S., Groome, N.P. et al. (1996) Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization\u2013embryo transfer. Clin. Endocrinol. (Oxf.), 45, 741\u2013748.","DOI":"10.1046\/j.1365-2265.1996.8510861.x"},{"key":"key\n\t\t\t\t20170410040147_MAGOFFIN-AND-JAKIMIUK-1998","doi-asserted-by":"crossref","unstructured":"Magoffin, D.A. and Jakimiuk, A.J. (1998) Inhibin A, inhibin B and activin A concentrations in follicular fluid from women with polycystic ovary syndrome. Hum. Reprod., 13, 2693\u20132698.","DOI":"10.1093\/humrep\/13.10.2693"},{"key":"key\n\t\t\t\t20170410040147_MATHER-ETAL-1997","doi-asserted-by":"crossref","unstructured":"Mather, J.P., Moore, A. and Li, R.H. (1997) Activins, inhibins, and follistatins: further thoughts on a growing family of regulators. Proc. Soc. Exp. Biol. Med., 215, 209\u2013222.","DOI":"10.3181\/00379727-215-44130"},{"key":"key\n\t\t\t\t20170410040147_MCCONNELL-ETAL-1998","doi-asserted-by":"crossref","unstructured":"McConnell, D.S., Wang, Q., Sluss, P.M. et al. (1998) A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state. J. Clin. Endocrinol. Metab., 83, 851\u2013858.","DOI":"10.1210\/jc.83.3.851"},{"key":"key\n\t\t\t\t20170410040147_MICHEL-ETAL-1998","doi-asserted-by":"crossref","unstructured":"Michel, U., Shintani, Y. and Nau, R. (1998) Serum follistatin concentrations are increased in patients with septicaemia. Clin. Endocrinol. (Oxf.), 48, 413\u2013417.","DOI":"10.1046\/j.1365-2265.1998.00484.x"},{"key":"key\n\t\t\t\t20170410040147_MUTTUKRISHNA-ETAL-1996","unstructured":"Muttukrishna, S., Fowler, P.A., George, L. et al. (1996) Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy. J. Clin. Endocrinol. Metab., 81, 3328\u20133334."},{"key":"key\n\t\t\t\t20170410040147_MUTTUKRISHNA-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Muttukrishna, S., Child, T., Lockwood, G.M. et al. (2000) Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women. Hum. Reprod., 15, 549\u2013556.","DOI":"10.1093\/humrep\/15.3.549"},{"key":"key\n\t\t\t\t20170410040147_NORMAN-ETAL-2001","doi-asserted-by":"crossref","unstructured":"Norman, R.J., Milner, C.R., Groome, N.P. and Robertson, D.M. (2001) Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome. Hum. Reprod., 16, 668\u2013672.","DOI":"10.1093\/humrep\/16.4.668"},{"key":"key\n\t\t\t\t20170410040147_PHILLIPS-ETAL-2000A","doi-asserted-by":"crossref","unstructured":"Phillips, D.J., Jones, K.L., McGaw, D.J. et al. (2000a) Release of activin and follistatin during cardiovascular procedures is largely due to heparin administration. J. Clin. Endocrinol. Metab., 85, 2411\u20132415.","DOI":"10.1210\/jc.85.7.2411"},{"key":"key\n\t\t\t\t20170410040147_PHILLIPS-ETAL-2000B","doi-asserted-by":"crossref","unstructured":"Phillips, K.P., Leveille, M.C., Claman, P. et al. (2000b) Changes in serum inhibin, activin and follistatin concentrations during puberty in girls. Hum. Reprod., 15, 1052\u20131057.","DOI":"10.1093\/humrep\/15.5.1052"},{"key":"key\n\t\t\t\t20170410040147_ROBERTS-ETAL-1994","unstructured":"Roberts, V.J., Barth, S., el-Roeiy, A. et al. (1994) Expression of inhibin\/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab., 79, 1434\u20131439."},{"key":"key\n\t\t\t\t20170410040147_ROBERTSON-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Robertson, D.M., Klein, R., de Vos, F.L. et al. (1987) The isolation of polypeptides with FSH suppressing activity from bovine follicular fluid which are structurally different to inhibin. Biochem. Biophys. Res. Commun., 149, 744\u2013749.","DOI":"10.1016\/0006-291X(87)90430-X"},{"key":"key\n\t\t\t\t20170410040147_SHIBATA-ETAL-1996","doi-asserted-by":"crossref","unstructured":"Shibata, H., Kanzaki, M., Takeuchi, T. et al. (1996) Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines. J. Mol. Endocrinol., 16, 249\u2013258.","DOI":"10.1677\/jme.0.0160249"},{"key":"key\n\t\t\t\t20170410040147_UENO-ETAL-1987","doi-asserted-by":"crossref","unstructured":"Ueno, N., Ling, N., Ying, S.Y. et al. (1987) Isolation and partial characterization of follistatin: a single-chain Mr 35 000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc. Natl Acad. Sci. USA, 84, 8282\u20138286.","DOI":"10.1073\/pnas.84.23.8282"},{"key":"key\n\t\t\t\t20170410040147_URBANEK-ETAL-1999","doi-asserted-by":"crossref","unstructured":"Urbanek, M., Legro, R.S., Driscoll, D.A. et al. (1999) Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc. Natl Acad. Sci. USA, 96, 8573\u20138578.","DOI":"10.1073\/pnas.96.15.8573"},{"key":"key\n\t\t\t\t20170410040147_URBANEK-ETAL-2000","doi-asserted-by":"crossref","unstructured":"Urbanek, M., Wu, X., Vickery, K.R. et al. (2000) Allelic variants of the follistatin gene in polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 85, 4455\u20134461.","DOI":"10.1210\/jc.85.12.4455"},{"key":"key\n\t\t\t\t20170410040147_VALE-ETAL-1990","doi-asserted-by":"crossref","unstructured":"Vale, W., Hsueh, A.J., Rivier, C. et al. (1990) The inhibin\/activin family of hormones and growth factors. In Sporn, M.B. and Roberts, A.B. (eds) Peptide Growth Factors and Their Receptors II. Springer-Vertag, New York, pp. 211\u2013248.","DOI":"10.1007\/978-3-642-74781-6_8"},{"key":"key\n\t\t\t\t20170410040147_YEN-1999","unstructured":"Yen, S.S.C. (1999) Polycystic Ovary Syndrome (Hyperandrogenic Chronic Anovulation). In Yen, S.S.C., Jaffe, R.B. and Barbieri, R.L (eds) Reproductive Endocrinology, 4th edition, W.B. Saunders Company, Philadelphia, Pennsylvania USA, pp. 436\u2013478."}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/16\/12\/2552\/11514074\/0162552.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T18:03:14Z","timestamp":1512583394000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article-lookup\/doi\/10.1093\/humrep\/16.12.2552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":38,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2001,12]]},"published-print":{"date-parts":[[2001,12]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/16.12.2552","relation":{},"ISSN":["1460-2350","0268-1161"],"issn-type":[{"value":"1460-2350","type":"electronic"},{"value":"0268-1161","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}